Results 91 to 100 of about 100,230 (154)

The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in <i>Drosophila melanogaster</i>. [PDF]

Int J Mol Sci
Vecchie' D, Wolter JM, Perry J, Jumbo-Lucioni P, De Luca M.   +4 more
europepmc   +1 more source

The Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes. [PDF]

Am J Gastroenterol
Wang RX, Serper M, Taddei TH, Kaplan DE, Kaplan DE, Mahmud N.   +5 more
europepmc   +1 more source

Association of SLCO1B1 gene variants with angiotensin-converting enzyme inhibitor-induced cough in a Pakistani hypertensive cohort. [PDF]

Front Pharmacol
Sheikh AF, Munawar N, Nawaz R, Khan H, Rafique M, Jahan F, Ahmed S.   +6 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitor-induced bowel angioedema: clinical features, diagnostic challenges, and recovery predictors from survival analysis: a systematic review of current reported cases. [PDF]

Ann Gastroenterol
Suenghataiphorn T, Tribuddharat N, Danpanichkul P, Kulthamrongsri N, Kantagowit P.   +4 more
europepmc   +1 more source

Neonatal Renal Failure Following Intrauterine Exposure to an Angiotensin-Converting Enzyme Inhibitor. [PDF]

Cureus
Rodrigues I, Quintela C, Jardim J, Pinto H, Pissarra S, Soares H, Soares P.   +6 more
europepmc   +1 more source

The therapeutic potential of angiotensin-converting enzyme inhibitor enalapril to ameliorate muscle atrophy in a murine model. [PDF]

EXCLI J
Seifi S, Nazari SE, Avan A, Khalili-Tanha N, Asgharzadeh F, Babaei F, Khalili-Tanha G, Asghari SZ, Darroudi M, Ferns GA, Marjani A, Khazaei M.   +11 more
europepmc   +1 more source

Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease. [PDF]

Lab Invest
Al Tuhaifi T, Zhong J, Yang HC, Fogo AB.
europepmc   +1 more source

Bioactive, Pro-Apoptotic-Angiotensin Converting Enzyme Inhibitor Effects and Properties of Ultrasound-Treated Traditional Poppy Vinegar Using the Response Surface Methodology Model. [PDF]

ACS Omega
Yıkmış S, Bozgeyik E, Tokatlı Demirok N, İlaslan K, Aadil RM.   +4 more
europepmc   +1 more source

A Five-Year Prospective, Randomized, Open-Label Study of Standard-Dose Versus Low-Dose Prolonged-Release Tacrolimus With or Without Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. [PDF]

Clin Transplant
Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Prasad GVR, Senécal L, Wolff JL, Schwartz JJ, Rush DN.   +12 more
europepmc   +1 more source